Mobile Technology: The Missing Link Between Health and Social Care Integration?
By Colin Reid, CEO of TotalMobile Ltd.It is no secret that health and social care integration is high on the UK Government's agenda, particularly in regards to looking after older people. Our aging society is forcing local organisations such as councils, NHS trusts, GPs and their Clinical Commissioning Groups (CCGs) to work closer together, and there is a lot of strategic discussion and debate as to how to meet the Government's directives.
IBM (NYSE: IBM) scientists are collabo-rating with pathologists at the University Hospital Zürich to test a new proto-type tool to accurately diagnose different types of cancer. This work is based on a technology developed by IBM scientists called a microfluidic probe, which slightly resembles the nib of a fountain pen. 
Advanced Health & Care (Advanced) has announced the launch of Caresys version 8, the latest version of the software company's widely used end-to-end care home management solution. The new version includes many new features including an updated user interface, designed to enhance navigation. 
Eucomed, the European medical technology industry association, welcomes the majority of measures adopted in a plenary vote by the European Parliament on the revision of the EU Medical Devices Directive (MDD). Members of the European Parliament (MEPs) have voted for much-needed measures to improve Europe's notified body system, increase the transparency and traceability of medical devices, introduce unannounced site visits and provide for better stakeholder involvement. 
This year, Siemens Healthcare held its third contest regarding outstanding results in clinical imaging in computed tomography. Starting today, members of the public with an interest in CT are invited to go online and vote for the best image in the "Right Dose Image Contest." In addition to the public vote, winners of a "Right Dose Excellence Award" will be chosen by an international jury of experts for eight specialist categories. 
Royal Philips (NYSE: PHG, AEX: PHIA) reports third-quarter comparable sales growth of 3% to EUR 5.6 billion; operational results improve by 33% to EUR 634 million. Healthcare currency-comparable equipment order intake declined by 2% year-on-year, with lower order intake at Patient Care & Clinical Informatics, while Imaging Systems recorded a slight increase.